Prescription drug · NDA
Marcaine Spinal (Bupivacaine hydrochloride in dextrose) NDC 0409-1761
Bupivacaine hydrochloride 7.5 mg/mL · Injection, Solution · Subarachnoid · Hospira, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0409-1761-10 | 0040917611000409176110 | 2 CELLO PACK in 1 CARTON (0409-1761-10) / 5 AMPULE in 1 CELLO PACK (0409-1761-05) / 2 mL in 1 AMPULE (0409-1761-18)Marketed from Aug 1, 2022 | |
| 0409-1761-62 | 0040917616200409176162 | 800 AMPULE in 1 CASE (0409-1761-62) / 2 mL in 1 AMPULE (0409-1761-18)Marketed from May 19, 2005 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Marcaine Spinal
- Generic name (nonproprietary)
- bupivacaine hydrochloride in dextrose
- Active ingredients
- Bupivacaine hydrochloride — 7.5 mg/mL
- Dosage form
- Injection, Solution
- Route
- Subarachnoid
- Labeler
- Hospira, Inc.NDC labeler code 0409
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018692
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 0409-1761_ef77810e-d05c-4501-9512-10dbe0bc7f00SPL ID ef77810e-d05c-4501-9512-10dbe0bc7f00SPL set ID 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0RxCUI 1724784, 1724792UNII 7TQO7W3VT8
- Pharmacologic class
- Amide Local Anesthetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400409176110followed by a unit qualifier and the quantityPackage 00409-1761-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
MARCAINE SPINAL is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia). MARCAINE SPINAL is an amide-local anesthetic indicated in adults for subarachnoid injection for the production of subarachnoid block (spinal anesthesia). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0409-1761
- What is NDC 0409-1761?
- 0409-1761 is the product NDC for Marcaine Spinal (bupivacaine hydrochloride in dextrose), Bupivacaine hydrochloride 7.5 mg/mL injection, solution, listed with the FDA by Hospira, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Marcaine Spinal (Bupivacaine Hydrochloride in Dextrose).
- What is the active ingredient?
- Bupivacaine hydrochloride.
- Who is the labeler?
- Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Marcaine Spinal?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.